Home About Us Research & Development Investors & Media Careers Contact Us

News Highlights

December 15, 2014

Concert Pharmaceuticals to Be Added to NASDAQ Biotechnology Index

December 10, 2014
Concert Pharmaceuticals Names Thomas Auchincloss to Board of Directors and Chair of the Audit Committee

December 9, 2014
Jazz Pharmaceuticals and Concert Pharmaceuticals Provide JZP-386 Program Update



Welcome to Concert

Concert Pharmaceuticals is a clinical stage biopharmaceutical company. We apply our extensive knowledge of deuterium chemistry to discover and develop novel small molecule drugs.

In the News

Mass High Tech BioFlash: Concert -Good news for two of its partnered drugs
September 22, 2104

MedChem News
Deuterium Medicinal Chemistry: A New Approach to Drug Discovery and Development Read more

Issued U.S. Patents

Concert is building a broad patent estate. View List


Concert has presented at a number scientific meetings. View Poster presentations

  ©2009 Concert Pharmaceuticals, Inc.
Design by Digizyme
Home     Sitemap